Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
For Use With (Application)
- (2)
- (2,347)
- (79)
- (3)
- (1)
- (1)
- (2)
- (354)
- (6,091)
- (7)
- (2)
- (7)
- (2)
- (1)
- (1)
- (2)
- (6)
- (40)
- (2)
- (2)
- (2)
- (2)
- (1)
- (2)
- (3)
- (1)
- (157)
- (1)
- (3)
- (1)
- (5)
- (10)
- (26,065)
- (1)
- (2)
- (1)
- (21)
- (1)
- (12,629)
- (1,160)
- (2)
- (2)
- (8)
- (1)
- (110)
- (8)
- (2)
- (1)
- (8)
- (1)
- (1)
- (1)
- (44)
- (255)
- (159)
- (1)
- (7)
- (1)
- (1)
- (3)
- (4)
- (1)
- (11,338)
- (25)
- (3)
- (30)
- (14)
- (10)
- (72)
- (13)
- (78)
- (77)
- (34)
- (1)
- (13)
- (1)
- (1,156)
- (1)
- (157)
- (26)
- (8)
- (1)
- (2)
- (2)
- (1)
- (18)
- (2)
- (21,641)
- (2,890)
- (4)
- (2,842)
- (4)
- (6)
- (1)
- (1)
- (3)
- (1)
- (1)
- (1)
- (11,317)
- (3)
- (6)
- (1)
- (1)
- (6)
- (7)
- (5)
- (1)
- (6)
- (1)
- (5,573)
- (6)
- (4)
- (3)
- (11)
- (2)
- (4)
- (5)
- (4)
- (5)
- (1)
- (13,021)
- (1,863)
- (1)
- (1)
Conjugate
- (11)
- (1)
- (4)
- (2)
- (9)
- (8)
- (1)
- (24)
- (1)
- (3)
- (1)
- (1)
- (3)
- (2)
- (1)
- (9)
- (2)
- (1)
- (13)
- (5)
- (1)
- (2)
- (3)
- (35,861)
Recombinant
- (58)
- (34,769)
Form
- (1)
- (23,074)
- (9,214)
- (29)
- (146)
- (24)
- (35)
Regulatory Status
- (75)
- (30,541)
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Search Within Results
Keyword Search:
Clear All
1
–
15
of
40,112
results
Invitrogen™ Vaccinia Virus B18R (Carrier-Free) Recombinant Protein, eBioscience™
Recombinant Protein
| Content And Storage | -80°C |
|---|---|
| Purity or Quality Grade | >98% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Liquid |
| pH Range | 7.5 |
| Common Name | Vaccinia Virus B18R |
| Molecular Weight (g/mol) | 48 kDa |
| Gene Symbol | Vaccinia Virus-Encoded Neutralizing Type I Interferon Receptor; Type I IFN inhibitor |
| Endotoxin Concentration | <0.01 ng/μg |
| Sequence | Vaccinia Virus B18R, ammino acids His20-Glu351 (Accession # D01019) with a His-tag |
| Concentration | 0.5 mg/mL |
| Expression System | Insect cells |
| For Use With (Application) | Bioactivity,Functional Assay |
| Source | Vaccinia Virus |
| Protein Subtype | Recombinant |
| Name | Vaccinia Virus B18R (Carrier-Free) |
| Purification Method | Purified |
| Product Type | Protein |
| Biological Activity | Pre-incubation of recombinant IFN-alpha 2 A with 0.1 μg/mL B18R for 1 hour (at RT was found to completely neutralize the activity of 1 ng/mL IFN-alpha 2 a.) |
| Formulation | PBS with no preservative; pH 7.5 |
| Shelf Life | 12 Months |
| Protein Tag | His-tag |
| Species | Bovine,Human,Mouse,Pig,Rabbit,Rat |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | RSPO3 |
| Molecular Weight (g/mol) | 26.9 kDa |
| Gene Symbol | RSPO3 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MHPNVSQGCQ GGCATCSDYN GCLSCKPRLF FALERIGMKQ IGVCLSSCPS GYYGTRYPDI NKCTKCKADC DTCFNKNFCT KCKSGFYLHL GKCLDNCPEG LEANNHTMEC VSIVHCEVSE WNPWSPCTKK GKTCGFKRGT ETRVREIIQH PSAKGNLCPP TNETRKCTVQ RKKCQKGERG KKGRERKRKK PNKGESKEAI PDSKSLESSK EIPEQRENKQ QQKKRKVQDK QKSVSVSTVH |
| Expression System | CHO cells |
| For Use With (Application) | Control,Bioactivity |
| Source | CHO cells |
| Name | Human R-Spondin-3 |
| Accession Number | Q9BXY4 |
| Gene Alias | 2810459H04Rik; AW742308; Cabriolet; cristin 1; Cristin1; cristin-1; cysteine-rich and single thrombospondin domain-containing protein 1; hPWTSR; hRspo3; Nucleopondin; protein with TSP type-1 repeat; PWTSR; RGD1563246; Roof plate-specific spondin-3; Rspo3; R-spondin 3; R-spondin 3 homolog; R-spondin 3 homolog (Xenopus laevis); R-spondin 3-like protein; R-spondin-3; Thrombospondin type-1 domain-containing protein 2; thrombospondin, type I, domain 2; thrombospondin, type I, domain containing 2; Thsd2; Unknown (protein for MGC:137973) |
| Biological Activity | R-Spondin-3 enhances BMP-2-mediated differentiation of MC3T3-E1 cells. The expected ED50 for this effect is 0.8 -2.0 ug/ml |
| Gene ID (Entrez) | 84870 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | CXCL12 alpha |
| Molecular Weight (g/mol) | 8 kDa |
| Gene Symbol | CXCL12 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | KPVSLSYRCP CRFFESHVAR ANVKHLKILN TPNCALQIVA RLKNNNRQVC IDPKLKWIQE YLEKALNK |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Human CXCL12 (SDF-1a) |
| Accession Number | P48061 |
| Gene Alias | 12-O-tetradecanoylphorbol 13-acetate repressed protein 1; C Cmotif chemokine; C X C motif chemokine; CC motif chemokine; CCmotif chemokine; chemokine (C-X-C motif) ligand 12; chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1); CXC; CXC motif chemokine; C-X-C motif chemokine 12; C-X-C motif chemokine ligand 12; CXCL; Cxcl12; H-SDF-1-alpha; Intercrine reduced in hepatomas; IRH; Pbsf; pre-B cell growth-stimulating factor; pre-B-cell growth-stimulating factor; SCYB12; SDF 1 a; SDF 1 alpha; SDF 1α; SDF1; SDF-1; SDF1 alpha; SDF-1 gamma; SDF1A; SDF-1-alpha(3-67); SDF1B; SDF-1-beta(3-72); SDF1α; Stromal cell-derived factor 1; stromal cell-derived factor-1 alpha; stromal cell-derived factor-1 gamma; thymic lymphoma cell-stimulating factor; TLSF; Tpar1 |
| Biological Activity | Determined by its ability to chemoattract IL-2-activated human T cells using a concentration range of 20.0-80.0 ng/ml |
| Gene ID (Entrez) | 6387 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
